B-cell involvement in the pathogenesis of RA-is there a contribution of the sympathetic nervous system?
- PMID: 18213527
- DOI: 10.1007/s12026-007-8002-0
B-cell involvement in the pathogenesis of RA-is there a contribution of the sympathetic nervous system?
Abstract
The pathogenesis of rheumatoid arthritis (RA), the most common rheumatic disease, is still an unsolved puzzle. For many years, T-cells were the main focus of research, but recently, the B-cell drew more and more attention not least, due to the observation in humans that the anti-CD20 antibody Retuximab, which selectively depletes subsets of B-cells, lessens disease symptoms. A second novel approach to understand pathomechanisms that contribute to the development and progression of arthritis focuses on the sympathetic nervous system, which is known to moderate the function of immune cells, e.g., the B-cell, and therefore, is tied into a complex neuroimmune network that influences the course of the disease. This review first discusses current research that shows the significance of B-cells in the pathogenesis of RA. It then gives a short review of knowledge regarding the role of the sympathetic nervous system (1) in RA pathogenesis and (2) in modulating B-cell responses. Finally, the hypothesis is introduced that the sympathetic nervous system via modulating B-cell function, e.g., antibody production, influences the development and progression of RA.
Similar articles
-
B-cell: a logical target for treatment of rheumatoid arthritis.Clin Exp Rheumatol. 2007 Mar-Apr;25(2):318-28. Clin Exp Rheumatol. 2007. PMID: 17543163 Review.
-
Crossroads of B cell activation in autoimmunity: rationale of targeting B cells.J Rheumatol Suppl. 2006 May;77:3-11. J Rheumatol Suppl. 2006. PMID: 16652439 Review.
-
B-cells and their targeting in rheumatoid arthritis--current concepts and future perspectives.Autoimmun Rev. 2011 Nov;11(1):28-34. doi: 10.1016/j.autrev.2011.06.010. Epub 2011 Jul 14. Autoimmun Rev. 2011. PMID: 21777703 Review.
-
Long term treatment of rheumatoid arthritis with rituximab.Autoimmun Rev. 2009 Jun;8(7):591-4. doi: 10.1016/j.autrev.2009.02.008. Epub 2009 Feb 11. Autoimmun Rev. 2009. PMID: 19393205
-
Treatment of inflammatory immunologic disease 4. B cell targeting therapy using the anti-CD20 antibody rituximab in inflammatory autoimmune diseases.Intern Med. 2007;46(16):1313-5. doi: 10.2169/internalmedicine.46.1914. Epub 2007 Aug 15. Intern Med. 2007. PMID: 17704614 No abstract available.
Cited by
-
β2-Adrenergic Receptor Expression and Intracellular Signaling in B Cells Are Highly Dynamic during Collagen-Induced Arthritis.Biomedicines. 2022 Aug 11;10(8):1950. doi: 10.3390/biomedicines10081950. Biomedicines. 2022. PMID: 36009497 Free PMC article.
-
Rheumatoid arthritis: Disease or syndrome?Open Access Rheumatol. 2009 Dec 8;1:179-192. doi: 10.2147/oarrr.s7680. eCollection 2009. Open Access Rheumatol. 2009. PMID: 27789990 Free PMC article. Review.
-
Autoinflammatory and autoimmune contributions to complex regional pain syndrome.Mol Pain. 2018 Jan-Dec;14:1744806918799127. doi: 10.1177/1744806918799127. Epub 2018 Aug 20. Mol Pain. 2018. PMID: 30124090 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical